SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 198.64-0.8%3:52 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (13626)1/23/1998 9:05:00 AM
From: Russian Bear  Read Replies (1) of 32384
 
Henry,

Thanks for the PFE/droloxifene information.

Two questions:

1. How does droloxifene compare with LLY's raloxifene? (I realize you may not have all the "hard" information you need to answer this, but I would still like to know your best guess.)

2. Assuming the pIII testing goes well for osteo, what is your new estimate for droloxifene's NDA / appearance on pharmacy shelves?

Thanks for your insights, as always.

RB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News